CA10919W4056 - Common Stock
BRIGHT MINDS BIOSCIENCES INC
NASDAQ:DRUG (9/17/2024, 8:01:31 PM)
1.29
+0.05 (+4.03%)
Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company is headquartered in New York City, New York. The company went IPO on 2021-02-08. The firm is focused on developing transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as treatment resistant epilepsy, treatment resistant depression, post-traumatic stress disorder (PTSD), and pain. Its pipeline includes BMB-101, BMB-202, and BMB-xxx. BMB-101 is for the treatment of Dravet syndrome and other neurological and neuro-psychiatric disorders. The firm has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling while avoiding off-target effects.
BRIGHT MINDS BIOSCIENCES INC
19 Vestry Street
New York City NEW YORK
P: 16478658622
Employees: 0
Website: https://brightmindsbio.com/
/PRNewswire/ - Bright Minds Biosciences Inc. (NASDAQ: DRUG), a biotechnology company focused on developing novel therapies for neurological and...
/CNW/ - Bright Minds Biosciences Inc. (NASDAQ: DRUG), a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric...
Bright Minds Biosciences just reported results for the third quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bright Minds Biosciences (NASDAQ:DRUG) just reported results for the third quar...
It's time to dive into the biggest pre-market stock movers for Monday morning with all of the latest news affecting shares today!
Bright Minds Biosciences just reported results for the second quarter of 2024.
Here you can normally see the latest stock twits on DRUG, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: